A phase 1 dose escalation study of the IDH1m inhibitor, FT-2102, in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) Meeting Abstract
| Authors: | Watts, J. M.; Baer, M. R.; Lee, S.; Yang, J.; Dinner, S. N.; Prebet, T.; Schiller, G. J.; Seiter, K.; Ferrell, P. B.; Kelly, P. F.; Li, P.; Sweeney, J.; Watson, C.; Mohamed, H.; Cortes, J. E. |
| Abstract Title: | A phase 1 dose escalation study of the IDH1m inhibitor, FT-2102, in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 381s |
| Language: | English |
| ACCESSION: | WOS:000442916002508 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.7009 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7009 -- Source: Wos |
